01 April 2022

Hospitals in England are to get access to new technologies to treat a range of conditions, including sickle cell disease, it has been announced.

NHS England said it had given approval to seven new devices and techniques in total.

This includes an automated blood cell replacement system for treating patients with sickle cell disease. The device, called Spectra Optia, performs therapeutic apheresis and cell processing. This enables it to identify diseased blood cells and replaces them with healthy donor cells, NHS England said.

NHS England said the new devices would collectively save the NHS up to £57.5 million a year.

NHS chief executive Amanda Pritchard said: “The NHS has always been at the forefront of medical innovations and while many of these gadgets may be small, they will make a huge difference to the lives of tens of thousands of patients every year as well as freeing up time for NHS staff.

“These cutting-edge devices show how the NHS is embracing the latest lifechanging technology and rolling it out at speed for patients across the country.”

UK Health Secretary Sajid Javid said: “As the country moves out of the pandemic, we have been clear that it cannot be business as usual. Offering patients innovative treatments like these is a key part of our strategy in tackling the COVID backlog.

“By supporting the NHS to harness new technology and adopt more efficient ways of working – from community diagnostic hubs to surgical hubs – we can relieve pressure on staff and make sure thousands of patients get the help they need more quickly.”

Source: NHS England


Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in Haematology. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.

News service provided by Englemed News.